Peru immigrant built career on helping local Hispanics
Aida McCammon has spent 20 years helping Hispanics improve their lives and succeed in the United States.
Health Care & Insurance
Articles
HICKS: Unfortunately, veteran tuition benefits must be cut
It’s a wide entitlement program that will literally explode in the coming decades, since a third of all combat veterans will meet the disability requirements. It is not sustainable, and the Senate just tightened the requirements.
Lilly confident of FDA approval for Amyvid, Lechleiter says
Eli Lilly and Co. CEO John Lechleiter said he’s confident of gaining U.S. regulatory approval for a drug to help identify plaque in the brain associated with Alzheimer’s disease.
Q&A: Tony Lennen
Tony Lennen became president of Community Hospital South in 2009, overseeing a 50-bed expansion that was completed last summer, giving the hospital 150 private rooms. The facility, located along the line between Marion and Johnson counties, competes against nearby facilities run by Franciscan St. Francis Health, Indiana University Health and Johnson Memorial Hospital.
Health insurance costs spike worldwide
Think galloping health insurance costs are a problem unique to American employers? Think again. Medical costs paid by employer-focused health insurers rose by an average of 10 percent last year—identical to the United States.
Lilly suffers another bruise from Novo
The failure of its drug Bydureon to match the performance of Novo’s Victoza trims but doesn’t kill sales prospects for the highly touted diabetes drug.
CNO Financial Chairman Hilliard stepping down
R. Glenn Hilliard, 68, who has held the chairman's title since September 2003, said he will not seek re-election.
Pharmacist accused of netting $3.5 million through fraud
A Terre Haute pharmacist faces a possible 10-year prison sentence if convicted of health care fraud and money laundering in a scheme that netted him more than $3.57 million.
OneAmerica promotes CFO Davison to executive vice president
With the company recently doubling in size, CEO Dayton Molendorp wanted another executive to guide the company’s further growth.
Lilly’s Bydureon falls short of competitor in study
Bydureon, the diabetes drug being developed by Amylin Pharmaceuticals Inc., Eli Lilly and Co. and Alkermes Inc., didn’t control the disease better than Novo Nordisk A/S’s Victoza in a study.
Parks Foundation plans east-side farm for Gleaners
The Indianapolis Parks Foundation plans to use a $150,000 grant from Indiana University Health to start an organic farm on the east side of the city benefiting Gleaners Food Bank.
WellPoint sees strong enrollment in big accounts
WellPoint Inc. has already more than doubled the enrollment gains it expected in 2011 for national accounts that the health insurer administers for large employers.
DeVry wins abatements for nursing school
The Metropolitan Development Commission awarded the tax abatements for the nursing school, set to open in October, despite opposition from the Nora-Northside Community Council and Metropolitan School District of Washington Township.
Community wins sweepstakes for Johnson partnership
Community Health Network won a three-way race for a close partnership with Johnson Memorial Hospital, besting Franciscan St. Francis and Indiana University Health.
WellPoint expects employer biz to stagnate
Over the next five years, WellPoint Inc. expects the employer-sponsored insurance business to shrink slightly, forcing it to shift its focus to government-sponsored plans.
UPDATE: Bioanalytical researcher opening lab in Indianapolis
Advion BioServices is expected to open the lab at Purdue Research Park in Indianapolis in May with 49 employees. Some of the workers may come from Eli Lilly and Co., which is moving its drug-discovery bioanalytical operations to Advion as part of a partnership.
UPDATE: Lilly settles pollution suit for $337,500
A complaint filed Wednesday by the U.S. government says Lilly’s plant on South Harding Street is emitting high levels of acetonitrile and methanol, considered hazardous air pollutants by the EPA.
Eli Lilly neuroscience chief resigns
David Bredt, vice president of neuroscience research, has resigned “to pursue other opportunities,” according to Lilly spokeswoman Judy Kay Moore. Bredt had overseen Lilly’s development of various drugs, including molecules in late-stage human testing to treat Alzheimer’s and depression.
WellPoint board declares 25-cent dividend
WellPoint Inc. became the latest health insurer to reward shareholders with a quarterly payout after piling up cash from a string of strong financial performances.
UPDATE: CNO shares soar after quarterly profit rises
The Carmel-based life and health insurer, in an after-markets announcement, said it earned $168.2 million in the final three months of last year, a big jump from the $18.2 million profit it posted in the same quarter the prior year.